MA46239A - Mousse pharmaceutique stable - Google Patents

Mousse pharmaceutique stable

Info

Publication number
MA46239A
MA46239A MA046239A MA46239A MA46239A MA 46239 A MA46239 A MA 46239A MA 046239 A MA046239 A MA 046239A MA 46239 A MA46239 A MA 46239A MA 46239 A MA46239 A MA 46239A
Authority
MA
Morocco
Prior art keywords
stable pharmaceutical
pharmaceutical foam
foam
stable
pharmaceutical
Prior art date
Application number
MA046239A
Other languages
English (en)
French (fr)
Inventor
Tamar Auerbach-Nevo
Ashley Deanglis
Israel Nur
Original Assignee
Ethicon Inc
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL247810A external-priority patent/IL247810A0/en
Application filed by Ethicon Inc, Omrix Biopharmaceuticals Ltd filed Critical Ethicon Inc
Publication of MA46239A publication Critical patent/MA46239A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • A61K9/122Foams; Dry foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/363Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061Use of materials characterised by their function or physical properties
    • A61L26/0085Porous materials, e.g. foams or sponges
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/04Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA046239A 2016-09-14 2017-09-11 Mousse pharmaceutique stable MA46239A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662394371P 2016-09-14 2016-09-14
IL247810A IL247810A0 (en) 2016-09-14 2016-09-14 Stable pharmaceutical foam

Publications (1)

Publication Number Publication Date
MA46239A true MA46239A (fr) 2019-07-24

Family

ID=60022140

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046239A MA46239A (fr) 2016-09-14 2017-09-11 Mousse pharmaceutique stable

Country Status (9)

Country Link
EP (1) EP3512502A1 (ko)
JP (1) JP7114597B2 (ko)
KR (1) KR102656742B1 (ko)
CN (1) CN109789091A (ko)
AU (1) AU2017328480A1 (ko)
CA (1) CA3036770A1 (ko)
IL (1) IL265252B2 (ko)
MA (1) MA46239A (ko)
WO (1) WO2018051325A1 (ko)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2492458A (en) 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
CH264752A (de) * 1947-06-03 1949-10-31 Hoffmann La Roche Verfahren zur Herstellung von Trägern für Arzneimittel.
JPS5814813B2 (ja) * 1976-11-09 1983-03-22 味の素株式会社 起泡剤及びその製造法
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
ES2242631T3 (es) 1999-07-21 2005-11-16 Imedex Biomateriaux Espuma de una proteina adhesiva para usos quirurgicos y/o terapeuticos.
EP1257304B1 (en) 2000-02-25 2004-02-04 David Sierra Foam-forming wound dressing
CN1250605C (zh) * 2001-03-26 2006-04-12 拜尔公司 具有显著剪切变稀行为的聚碳酸酯
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US6749842B2 (en) * 2002-01-24 2004-06-15 Midwest Grain Products Liquid foam builder containing hydrolyzed grain protein
US8202549B2 (en) 2007-08-14 2012-06-19 The Regents Of The University Of California Mesocellular oxide foams as hemostatic compositions and methods of use
CA2710798A1 (en) * 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
EP2259803B2 (en) * 2008-02-29 2019-03-13 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
EP2252335B1 (en) * 2008-03-03 2013-04-24 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US8753670B2 (en) 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
US20110036133A1 (en) * 2008-04-18 2011-02-17 N. V. Organon Purification of protein hydrolysate and the result and products
US20100021527A1 (en) 2008-07-25 2010-01-28 Chunlin Yang Collagen-related peptides and uses thereof and hemostatic foam substrates
US8778883B2 (en) 2009-11-13 2014-07-15 Industrial Technology Research Institute Foamy biomaterial for biological tissue repair
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
US8680240B1 (en) 2012-11-01 2014-03-25 George David Falus Tissue sealant for use in non-compressible hemorrhage
EP2928511B1 (en) 2012-12-07 2020-04-22 Baxter International Inc. Hemostatic foam
CN105543315A (zh) * 2015-12-16 2016-05-04 陕西科技大学 胶原蛋白类发泡剂、其复配改性发泡剂以及二者的制备方法

Also Published As

Publication number Publication date
KR102656742B1 (ko) 2024-04-15
CA3036770A1 (en) 2018-03-22
JP2019526646A (ja) 2019-09-19
IL265252B2 (en) 2023-11-01
JP7114597B2 (ja) 2022-08-08
IL265252B1 (en) 2023-07-01
KR20190054110A (ko) 2019-05-21
CN109789091A (zh) 2019-05-21
AU2017328480A1 (en) 2019-03-14
IL265252A (en) 2019-05-30
EP3512502A1 (en) 2019-07-24
WO2018051325A1 (en) 2018-03-22

Similar Documents

Publication Publication Date Title
DK3479819T5 (da) Stabilt væskeformigt farmaceutisk præparat
DK3529248T3 (da) Farmaceutiske sammensætninger
DK3328880T3 (da) Terapeutiske midler
MA50541A (fr) Formulations pharmaceutiques
MA46334A (fr) Composition pharmaceutique liquide
DK3634377T3 (da) Farmaceutisk formulering
DK3529240T3 (da) Farmaceutiske forbindelser
MA42303A (fr) Formulations pharmaceutiques
MA43705A (fr) Formulation pharmaceutique
MA43375A (fr) Mousse minérale ultra-légère
MA46867A (fr) Formulations pharmaceutiques
DK3463345T3 (da) Farmaceutiske kombinationer
DK3199161T3 (da) Farmaceutisk præparat
MA44987A (fr) Formulations de médicaments améliorées
DK3525897T3 (da) Spilsystem
DK3679010T3 (da) Kulsyre-additionsprodukter
MA42964A (fr) Préparation pharmaceutique anti-vieillissement
MA47516A (fr) Composition pharmaceutique
IL266537A (en) pharmaceutical preparation
MA49822A (fr) Combinaison pharmaceutique comprenant du ponesimod
DK3280447T3 (da) Farmaceutiske formuleringer
ZA201807851B (en) Pharmaceutical formulation
DK3601277T3 (da) Farmaceutisk formulering
CL2016002705A1 (es) Formulación agroquímica
SE1651557A1 (sv) Medical support